Product
Conditioning Regimen
1 clinical trial
5 indications
Indication
Myelodysplastic SyndromeIndication
Myeloproliferative NeoplasmsIndication
Chronic Myelomonocytic LeukemiaIndication
Atypical chronic myeloid leukemiaClinical trial
Phase II Study of a Geriatric Assessment-Driven, Risk-Adapted Allogeneic Hematopoietic Cell Transplant Strategy for Older Patients With Myeloid MalignanciesStatus: Active (not recruiting), Estimated PCD: 2025-02-01